First line hormone treatment of hormone-dependent metastatic breast cancer in postmenopausal patients. Fareston is not recommended for patients with estrogen receptor negative tumours.
Keryx Biopharmaceuticals has announced that the FDA has approved Ferric Citrate (formerly known as Zerenex) for the control of serum...